tirzepatide the villages Medical Weight Loss Semaglutide GLP-1 vs Tirzepatide for

It's not seen with: Semaglutide (Wegovy/Ozempic): 10% body weight quickly Hypoglycemia (Low Blood Sugar): Rare in non-diabetics ( perceived benefit) Timeline of Side Effects: What to Expect Week by Week Week 14: Initial Dose (2mg) What's happening: Body adjusting to GLP-1 activation Common side effects: Mild nausea (2030%): Usually 12 hours after injection Reduced appetite (desired!) Occasional loose stools Mild fatigue Duration: Usually 25 days after each injection, then improves Management: Take with food, stay hydrated, avoid high-fat meals Week 58: First Dose Increase (4mg) What's happening: GLP-1 effects intensifying Common side effects: Nausea increases (3040%) Diarrhea or constipation (1525%) Fullness sensation (desired effect) Energy fluctuations Duration: Peak in first 23 days after dose increase, then stabilizes Management: Smaller, more frequent meals

The Wegovy label now covers injection across six strengths including a 7.2 mg Wegovy HD pen approved in March 2026, single-dose syringes, a single-patient-use FlexTouch pen delivering four 2.4 mg doses, and Wegovy tablets at 1.5, 4, 9 and 25 mg approved in December 2025

As well as guidance on how and where to self-administer the weekly injection

This spray from Betteryou contains the most bioavailable form of B12 (methylcobalamin) which is a naturally active form found within human metabolism

Retatrutide: the triple agonist If tirzepatide was revolutionary as a dual agonist, retatrutide aims to be transformative as a triple agonist

Se il paziente non viene educato a gestire diversamente lalimentazione e il proprio rapporto con il cibo, nel tempo potrebbe tornare a mangiare in modo scorretto anche continuando la terapia